Monday, 16 June 2014

Researchmoz : Fina Biotech - Product Pipeline Analysis, 2014 Update

ResearchMoz.us include new market research report" Fina Biotech - Product Pipeline Analysis, 2014 Update" to its huge collection of research reports.

Fina Biotech (Fina) is a biotechnology company. The company selects, finances, conducts, develops and sells biotechnology projects. It offers in vitro diagnostic product Halosperm, which is a kit to determine the degree of DNA fragmentation in human sperm, using sperm chromatin dispersion (SCD) technique. It produces new tools for monitoring, diagnosis, prognosis and treatment of significant diseases.


Fina investments in the areas of oncology, cardiology and stem cell therapy. The companys diagnostics areas include bladder cancer, restenosis, bio energetic signature, prostate cancer, colon cancer, deep vein thromobos, myocardial infarction, and brain stroke. It partners with halotech, SF biotech, abg patentes, HERRERO & ASOCIADOS, and others. Fina is headquartered in Madrid, Spain.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Fina Biotech
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

For More Information Kindly Contact:

No comments:

Post a Comment